Case report identifies gene changes in FBN1 linked to Marfan syndrome — Evidence Review

Two domestic cats have been diagnosed with Marfan syndrome, marking the first molecularly characterized cases in felines, according to a new study. Related research broadly supports the role of FBN1 mutations in connective tissue disorders, aligning with these findings from Cornell University{:target="_blank" rel="noopener noreferrer"}.

• FBN1 gene mutations are well-established as the cause of Marfan syndrome and similar connective tissue disorders in humans; the new study extends this association to domestic cats, reinforcing the fundamental importance of fibrillin-1 in connective tissue health across species 1 2 4.
• Human cases typically require only one mutant FBN1 allele for disease manifestation, while the affected cats possessed two altered copies, an unusual genetic context that provides new insights into genotype-phenotype relationships and disease severity 2 4 5 11.
• Prior research highlights the variability of Marfan syndrome presentations and the complexity of genotype-phenotype correlations, which is consistent with the survival and phenotype of these cats despite their biallelic mutations 4 5 11.

Study Overview and Key Findings

Marfan syndrome is a well-recognized inherited disorder in humans, characterized by abnormalities in connective tissues affecting the skeleton, eyes, and cardiovascular system. However, until now, this syndrome had not been documented at the molecular level in domestic cats. This study is notable for its interdisciplinary approach, combining clinical veterinary observations with genetic analysis to identify the first confirmed feline cases. The research also provides a rare opportunity to investigate how different patterns of FBN1 mutations influence disease severity and survival across species.

Property	Value
Organization	Cornell University
Journal Name	Scientific Reports
Authors	Dr. Jacquelyn Evans
Population	Two long-legged domestic cats with genetic disorder
Methods	Case Report
Outcome	Molecular characterization of Marfan syndrome
Results	Identified gene changes in FBN1 affecting connective tissue

Literature Review: Related Studies

To contextualize the new findings, we searched the Consensus database, which contains over 200 million scientific papers. The following search queries were used to identify relevant research:

1. FBN1 gene mutations connective tissue disorder
2. genetic disorders connective tissue pathology
3. rare genetic conditions FBN1 gene impact

Literature Review Table

Topic	Key Findings
What is the genetic basis of Marfan syndrome and related disorders?	- FBN1 mutations are responsible for Marfan syndrome, with over a thousand variants documented and significant genotype-phenotype variability 1 2 4 5 11. - The disorder is primarily autosomal dominant in humans, with manifestations in the skeleton, cardiovascular system, and eyes 1 2 4.
How do FBN1 mutations impact phenotype and disease severity?	- Mutation type and location in FBN1 affect clinical outcomes; exons 24-32 mutations are linked to more severe phenotypes 4 5 11. - Biallelic or certain missense mutations can result in more severe or atypical presentations, including neonatal or recessive forms 4 11.
How do connective tissue disorders differ and overlap genetically?	- Marfan, Ehlers-Danlos, and Loeys-Dietz syndromes have overlapping features but distinct genetic causes; EDS is often caused by collagen gene mutations, while Marfan is linked to FBN1 3 6 7 8 9. - Differential diagnosis is challenging due to phenotypic overlap; molecular testing is essential for accurate classification 3 8 10.
What is known about FBN1-related disorders beyond Marfan syndrome?	- FBN1 mutations are also implicated in other connective tissue disorders, such as Weill-Marchesani and acromelic dysplasias, with varying clinical features 2 4 12. - Rare FBN1 and FBN2 variants are associated with conditions like adolescent idiopathic scoliosis, expanding the spectrum of fibrillinopathies 13.

---

What is the genetic basis of Marfan syndrome and related disorders?

Research consistently identifies mutations in the FBN1 gene as the primary cause of Marfan syndrome, with a wide array of individual mutations and significant variability in presentation. This new study's identification of FBN1 mutations in cats closely mirrors human findings and supports the cross-species relevance of this gene in connective tissue integrity.

• Over a thousand unique FBN1 mutations are linked to Marfan syndrome, complicating genotype-phenotype correlation efforts 2.
• Marfan syndrome is traditionally inherited in an autosomal dominant fashion in humans; most cases involve only one mutated allele 1 2 4.
• Clinical features include tall stature, long limbs, ectopia lentis, and cardiovascular abnormalities 1 2 4.
• The new feline cases represent the first well-documented example of this disorder outside humans, broadening understanding of FBN1’s role 1 2 4.

How do FBN1 mutations impact phenotype and disease severity?

The clinical impact of FBN1 mutations depends on the type and location of the mutation. Studies indicate that certain variants, especially those in exons 24-32 or involving biallelic mutations, are associated with severe disease. The discovery of cats surviving to adulthood with two altered FBN1 alleles adds a novel dimension to genotype-phenotype relationships.

• Premature termination codon and cysteine-altering variants are linked to more severe manifestations, including early aortic events and skeletal abnormalities 5 11.
• Exon 24-32 mutations in FBN1 are particularly associated with severe, early-onset forms of Marfan syndrome 11.
• Most human cases are heterozygous; biallelic mutations are rare and usually severe—survival into adulthood, as seen in the cats, is uncommon 4 11.
• The partial preservation of fibrillin-1 function in the cats may explain their milder phenotype compared to typical biallelic cases 4 5 11.

How do connective tissue disorders differ and overlap genetically?

Marfan syndrome, Ehlers-Danlos syndromes (EDS), and Loeys-Dietz syndrome (LDS) are all connective tissue disorders with overlapping but distinct genetic causes. Accurate diagnosis often requires molecular testing due to clinical similarities. The new study reinforces the importance of genetic testing in distinguishing between these conditions.

• Marfan syndrome is caused by FBN1 mutations, while LDS involves TGFβ pathway genes and EDS is associated with various collagen genes 3 8.
• Significant symptom overlap includes joint hypermobility, skin changes, and aortic disease, making clinical diagnosis challenging 3 6 7 8 9.
• EDS encompasses a heterogeneous group of disorders with 13–14 recognized subtypes and diverse genetic underpinnings 8 9 10.
• The first molecularly characterized feline Marfan cases highlight the need for species-specific diagnostic criteria and molecular analysis 3 8 10.

What is known about FBN1-related disorders beyond Marfan syndrome?

FBN1 mutations are implicated in a spectrum of connective tissue disorders beyond classic Marfan syndrome. These include syndromes with opposite features (e.g., short stature in acromelic dysplasias) and other phenotypes like adolescent idiopathic scoliosis, emphasizing the diverse effects of fibrillin-1 dysfunction.

• Specific FBN1 mutations can cause Weill-Marchesani and acromelic dysplasias, which feature short stature and stiff joints, contrasting with the tall stature of Marfan syndrome 2 4 12.
• Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis, even in patients who do not meet criteria for Marfan syndrome 13.
• The broad clinical spectrum attributed to FBN1 mutations suggests context-dependent effects on connective tissue 2 4 12 13.
• The new feline cases contribute to understanding how FBN1 mutations can manifest differently across species and genetic backgrounds 2 4 13.

Future Research Questions

Although this study provides novel insights into the genetics of feline connective tissue disorders, several questions remain. Further research is needed to better understand species differences, the mechanisms underlying disease variability, and the broader implications for veterinary and human medicine.

Research Question	Relevance
How do biallelic FBN1 mutations affect phenotype and survival across species?	Biallelic FBN1 mutations are rare in humans and animals; understanding their effects could clarify genotype-phenotype relationships and mechanisms of disease severity 4 5 11.
Are there other domestic animals with FBN1-related connective tissue disorders?	Investigating other species could reveal whether similar genetic disorders occur and improve comparative understanding of connective tissue pathology 1 2 4.
Can genetic testing improve diagnosis and management of Marfan-like syndromes in veterinary medicine?	The new study highlights diagnostic challenges; evaluating the utility of genetic tests could enhance clinical care for animals with suspected connective tissue disorders 3 8 10.
What molecular mechanisms allow partial FBN1 function in biallelic mutations?	The survival of cats with two mutated FBN1 alleles suggests that some variants retain partial gene function; elucidating these mechanisms could inform therapeutic strategies 4 5 11.
How do FBN1 mutations interact with other connective tissue genes to modulate phenotype?	The complexity of connective tissue disorders and the overlap between syndromes suggest gene-gene interactions that could influence clinical outcomes and disease variability 3 8 10.